Evidence map›Paper›PMID 35170427›Full record

ArticleeLife2022

Regulation of canonical Wnt signalling by the ciliopathy protein MKS1 and the E2 ubiquitin-conjugating enzyme UBE2E1.

Katarzyna Szymanska, Karsten Boldt, Clare V Logan, Matthew Adams, Philip A Robinson, Marius Ueffing, Elton Zeqiraj, Gabrielle Wheway, Colin A Johnson

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Autophagy and the primary cilium in cell metabolism: What's upstream?Frontiers in cell and developmental biology · 2022
    Review
  11. Islet cilia and glucose homeostasis.Frontiers in cell and developmental biology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Katarzyna SzymanskaLeeds Institute of Medical Research, School of Medicine, University of Leeds, Leeds, United Kingdom.ORCID 0000-0001-7736-5225
Karsten BoldtInstitute of Ophthalmic Research, Center for Ophthalmology, University of Tübingen, Tübingen, Germany.
Clare V LoganLeeds Institute of Medical Research, School of Medicine, University of Leeds, Leeds, United Kingdom.
Matthew AdamsLeeds Institute of Medical Research, School of Medicine, University of Leeds, Leeds, United Kingdom.
Philip A RobinsonLeeds Institute of Medical Research, School of Medicine, University of Leeds, Leeds, United Kingdom.
Marius UeffingInstitute of Ophthalmic Research, Center for Ophthalmology, University of Tübingen, Tübingen, Germany.ORCID 0000-0002-9045-182X
Elton ZeqirajAstbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.ORCID 0000-0003-0239-5926
Gabrielle WhewayLeeds Institute of Medical Research, School of Medicine, University of Leeds, Leeds, United Kingdom.
Colin A JohnsonLeeds Institute of Medical Research, School of Medicine, University of Leeds, Leeds, United Kingdom.ORCID 0000-0002-2979-8234
University of Leeds · GBUniversity of Tübingen · DE

Funding

Medical Research Council MR/K011154/1Medical Research Council MR/M000532/1Wellcome Trust 105615/Z/14/ZWellcome Trust 200523/Z/16/ZWellcome Trust 204378/Z/16/Z
6 · The paper itself

Abstract

Primary ciliary defects cause a group of developmental conditions known as ciliopathies. Here, we provide mechanistic insight into ciliary ubiquitin processing in cells and for mouse model lacking the ciliary protein Mks1. In vivo loss of Mks1 sensitises cells to proteasomal disruption, leading to abnormal accumulation of ubiquitinated proteins. We identified UBE2E1, an E2 ubiquitin-conjugating enzyme that polyubiquitinates β-catenin, and RNF34, an E3 ligase, as novel interactants of MKS1. UBE2E1 and MKS1 colocalised, and loss of UBE2E1 recapitulates the ciliary and Wnt signalling phenotypes observed during loss of MKS1. Levels of UBE2E1 and MKS1 are co-dependent and UBE2E1 mediates both regulatory and degradative ubiquitination of MKS1. We demonstrate that processing of phosphorylated β-catenin occurs at the ciliary base through the functional interaction between UBE2E1 and MKS1. These observations suggest that correct β-catenin levels are tightly regulated at the primary cilium by a ciliary-specific E2 (UBE2E1) and a regulatory substrate-adaptor (MKS1).

Indexed as

Wnt Signaling PathwayAnimalsbeta CateninCiliaCiliopathiesHumansMiceMice, KnockoutProteasome Endopeptidase ComplexProteinsUbiquitinUbiquitinationUbiquitin-Conjugating EnzymesUbiquitin-Protein Ligasesbeta CateninMKS1 protein, mouseProteasome Endopeptidase ComplexProteinsUbe2e1 protein, mouseUbiquitinUbiquitin-Conjugating EnzymesUbiquitin-Protein Ligasesbeta-catenincell biologyciliopathieshumanMKS1mouseprimary ciliaUBE2E1Wnt signalling

Identifiers

PMID35170427
PMCPMC8880992
OpenAlexW4220946435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.